Jacob Schilder

Title: Jacob Schilder: Innovator in Cell Culturing Technology

Introduction

Jacob Schilder is a notable inventor based in Kropswolde, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of cell culturing processes. With a total of 6 patents to his name, Schilder's work has advanced the methods used in producing biological substances, such as antibodies.

Latest Patents

One of Schilder's latest patents focuses on a process for the culturing of cells, specifically E1-immortalized HER cells, with a preference for PER.C6 cells. This innovative process involves culturing these cells in a reactor suspended in a cell culture medium. The cells are designed to produce a biological substance, preferably an antibody. The process includes feeding at least one component of the cell culture medium to the cells and circulating the culture over a separation system. This system effectively separates the biological substance from lower molecular weight substances, ensuring that the biological substance is retained or fed back into the reactor. Additionally, part of the lower molecular weight substances is continuously removed from the cell culture, enhancing the efficiency of the process.

Career Highlights

Throughout his career, Jacob Schilder has worked with prominent companies in the biotechnology sector. Notable among these are DSM IP Assets B.V. and Patheon Holdings B.V. His experience in these organizations has contributed to his expertise in cell culturing technologies and patent development.

Collaborations

Schilder has collaborated with several professionals in his field, including Gerben Meile Zijlstra and Robert Patrick Hoff. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Jacob Schilder's contributions to cell culturing technology demonstrate his commitment to advancing biotechnology. His innovative processes and collaborations have positioned him as a key figure in the industry.